Early postnatal estrogen organizes sex differences in the extinction of a CRF running response.
In the present study the organizational effects of sex steroids on the sexually dimorphic extinction of a continuously food-rewarded running response were investigated. Gonadally intact female rats neonatally treated from day 1 to day 8 of the postnatal life with estradiol benzoate (EB), dihydrotestosterone (DHT) or vehicle, and males treated in the same period with the antiandrogen ciproterone acetate (AC), the estrogen antagonist tamoxifen (TX) or vehicle were studied in adulthood during the acquisition and extinction phases of the response in a short and narrow runway. No difference in performance between groups was obtained in the response acquisition. However, during extinction control males extinguished faster than control females. DHT treatment to females and neonatal CA administration to males had no effect on the expression of sexual dimorphism. Conversely, TX administration to the males increased male's resistance to extinction at the levels shown by control or DHT females, whereas the females treated with EB exhibited similar extinction rates to those observed in nonhormonal treated or CA males. This finding suggests that the organizational effect of testosterone on the sexually dimorphic behavior studied in the present report are mediated by testosterone conversion to estradiol throughout the aromatization pathway in the brain.
Sánchez-Santed
F
F
Departamento de Psicobiología, Universidad Nacional de Educación a Distancia, Madrid, Spain.
Calés
J M
JM
Enriquez
P
P
Guillamón
A
A
D000818:Animals; D000831:Animals, Newborn; D003216:Conditioning, Operant / Q000187:drug effects*; D017373:Cyproterone Acetate / Q000494:pharmacology; D013196:Dihydrotestosterone / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D005108:Extinction, Psychological / Q000187:drug effects*; D005260:Female; D008024:Ligands; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D012055:Reinforcement Schedule; D012420:Running; D012727:Sex Characteristics; D013629:Tamoxifen / Q000494:pharmacology
D004967:Estrogens; D008024:Ligands; D013196:Dihydrotestosterone; D013629:Tamoxifen; D017373:Cyproterone Acetate; D004958:Estradiol